Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Antisocial personality disorder: prevention and management

Clinical guideline
Reference number: CG77
Published: 28 January 2009
Last updated: 27 March 2013

History

Stakeholder list updated

Stakeholder list (PDF 152 KB)

Published:

23 July 2018

Surveillance consultation

Surveillance consultation
Surveillance review proposal (PDF 823 KB)

Published:

30 April 2018
Comments form (MSWord 30 KB)

Published:

30 April 2018

Review documents

Review proposal consultation information
Consultation document (PDF 162 KB)

Published:

10 October 2011
Antisocial personality disorders (ASPD): list of stakeholders (PDF 24 KB)

Published:

10 October 2011
Review decision (PDF 168 KB)

Published:

17 November 2011
Static list review decision (PDF 1.38 MB)

Published:

17 February 2014

Antisocial personality disorders (ASPD): comments table responses

Antisocial personality disorders (ASPD): comments table responses (PDF 268 KB)

Published:

28 April 2009

Antisocial personality disorders (ASPD): consultation on the draft guideline

Antisocial personality disorders (ASPD): consultation on the draft guideline information
Antisocial personality disorders (ASPD): full guideline for consultation (PDF 1.23 MB)

Published:

08 August 2008
Antisocial personality disorders (ASPD): NICE guideline for consultation (PDF 170 KB)

Published:

08 August 2008
Antisocial personality disorders (ASPD): consultation appendices
Appendix 15: study characteristic tables (PDF 1.06 MB)

Published:

08 August 2008
Appendix 16: clinical evidence forest plots (MSWord 155 KB)

Published:

08 August 2008
Appendix 17: GRADE evidence profiles (MSWord 249 KB)

Published:

08 August 2008
Appendix 18a FFT model - estimated costs of FFT for 100 families (Excel 22 KB)

Published:

08 August 2008
Appendix 18b FFT model - estimated weighted cost of a crime (Excel 17 KB)

Published:

08 August 2008
Appendix 18c: R&R model (Excel 27 KB)

Published:

08 August 2008
Antisocial personality disorders (ASPD): list of stakeholders (PDF 24 KB)

Published:

10 October 2011

Antisocial personality disorders (ASPD): list of stakeholders

Antisocial personality disorders (ASPD): list of stakeholders (PDF 24 KB)

Published:

10 October 2011

Antisocial personality disorders (ASPD): Guidance development group

Antisocial personality disorders (ASPD): Guidance development group
Antisocial personality disorders (ASPD): Guidance development group list (PDF 24 KB)

Published:

07 March 2008
Antisocial personality disorders (ASPD): Guidance Development Group minutes - 10 October 2008 (PDF 33 KB)

Published:

10 November 2008
Antisocial personality disorders (ASPD): Guidance Development Group minutes - 8 February 2008 (PDF 21 KB)

Published:

27 May 2008
Antisocial personality disorders (ASPD): Guidance Development Group minutes - 11 April 2008 (PDF 37 KB)

Published:

27 May 2008

Scope consultation table with responses

Scope consultation table with responses (PDF 255 KB)

Published:

14 June 2007

Personality disorders - antisocial: final scope

Personality disorders - antisocial: final scope (PDF 124 KB)

Published:

19 March 2007

Personality disorders - antisocial: Draft scope

Personality disorders - antisocial: Draft scope (PDF 120 KB)

Published:

21 November 2006

Personality disorders - antisocial: Draft scope, comments form

Personality disorders - antisocial: Draft scope, comments form (MSWord 47 KB)

Published:

21 November 2006

The guideline development process - an overview for stakeholders, the public and the NHS (third edition)